Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial.

, p = 0.003), SN macro-metastases versus ITC (OR: 2.60, 1.31–5.15, p = 0.006), WBI or PMRT (OR: 3.93, 1.61–9.59, p = 0.003), grade SBR 2 and 3 (OR: 2.83, 2.03–3.95, p < 0.001 and 20.94, 11.0–39.9, p < 0.0001, respectively), pathologic tumor size 10–30 versus ≤10 mm (OR: 2.02, 1.35–3.00, p = 0.005), of borderline significance for pathologic tumor size >30 versus ≤10 mm (OR: 1.79, 0.98–3.25, p = 0.057) and >2 involved SN versus ≤2 (OR 3.19, CI 95% 0.86–11.84, p = 0.082), without significant difference between ALND and SLNB groups (groups of treatment realized).

also in 2,624 other papers